Thu Sep 19 06:13:39 UTC 2024: ## Pasithea Therapeutics Stock Soars 25.8% on Wednesday
**New York, NY (MarketBeat News) -** Pasithea Therapeutics Corp. (NASDAQ: KTTA) experienced a significant surge in its share price on Wednesday, closing at $5.80, a 25.8% increase from the previous day’s closing price of $4.61. The stock reached a high of $6.10 during the day, with an unusually high trading volume of 98,351 shares, representing an 832% increase from the average daily volume.
The company’s recent quarterly earnings report, released on August 13th, showed a loss of $3.71 per share for the quarter. Pasithea Therapeutics is a biotechnology company focused on developing treatments for central nervous system disorders, RASopathies, and other diseases. Their lead product candidate, PAS-004, is a next-generation MEK inhibitor for various RASopathies, including neurofibromatosis type 1 and oncology indications.
While the exact reason for the sudden surge in KTTA stock is unclear, the heightened trading volume and strong closing price suggest a renewed investor interest in the company.
**To stay updated on Pasithea Therapeutics and other related companies, subscribe to MarketBeat.com’s FREE daily email newsletter for concise summaries of the latest news and analyst ratings.**
First Piper 